FDA Investigator

Daniel L Zheng

Latest inspection on record: Bedford, United States, June 2026 · records back to 2020

Human DrugsAnimal Drugs & Feeds

FDA inspection record · Last updated July 12, 2026

Overview

  • 36 inspections across 35 sites are on record.
  • 178 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-10.

At a glance

Inspections

36

Sites

35

Observations

178

Career since

Nov 2020

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Lyophilization Services of New England, Inc. dba PCI Pharma Services10 Jun 2026Human DrugsView 483 →
Lantheus Medical Imaging, Inc.9 Apr 2026Human DrugsOn file
SCIARRA AEROMED, INC25 Feb 2026Animal Drugs & FeedsOn file
Fresenius Kabi Compounding, LLC5 Nov 2025Human DrugsView 483 →
Tropichem Research Labs LLC11 Sep 2025Animal Drugs & FeedsOn file

Sites inspected

Lantheus Medical Imaging, Inc.North Billerica, United States1 insp.
SCIARRA AEROMED, INCCarmel, United States1 insp.
Fresenius Kabi Compounding, LLCCanton, United States1 insp.
Tropichem Research Labs LLCJupiter, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Daniel L Zheng's 178 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site